Press releases | Finanzwire

Basculer en Français

9904	Companies
199556	Keywords
130422	Articles
106060	Press releases

Home
Press releases

PRESS RELEASE

published on 12/08/2025 at 08:00, 2 months 12 days ago

NON-DISCLOSURE OF INTERIM FINANCIAL RESULTS FOR THE FIRST HALF OF 2025
AgroGeneration, a producer of cereals and oilseeds in Ukraine, faces challenges in publishing its 2025 interim financial results due to loss of accounting documents from military actions. Euronext places shares in Penalty Bench pending annual report

Financial Results Euronext AgroGeneration Ukraine Military Actions
PRESS RELEASE

published on 12/08/2025 at 07:40, 2 months 12 days ago

UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder
UCB presents positive results from GEMZ phase 3 study at AES showing significant reduction in countable motor seizure frequency in CDKL5 Deficiency Disorder. Study demonstrates efficacy and safety of fenfluramine as adjunctive treatment

AES UCB Fenfluramine Seizure Reduction GEMZ Phase 3 Study
PRESS RELEASE

published on 12/08/2025 at 07:30, 2 months 12 days ago

Eight years of research and development – proprietary algorithms enable the strategic scaling of trading capacities
Alphawave GmbH concludes an 8-year R&D phase, introducing scalable trading capacities. Proprietary algorithms drive strategic trading. Impressive internal trading results shared

Research And Development Trading Capacities Proprietary Algorithms Alphawave GmbH Internal Trading Results
PRESS RELEASE

published on 12/08/2025 at 07:05, 2 months 12 days ago

Huawei Celebrates Türkiye's Leading Developers and Designers at Istanbul Awards Event
Huawei celebrates Türkiye's leading app developers and watch face designers at Istanbul Awards event, reinforcing commitment to innovation and local talent

Innovation Türkiye Designers Developers Huawei
PRESS RELEASE

published on 12/08/2025 at 07:00, 2 months 12 days ago

Xlife Sciences AG Announces Exit of 12 Project Companies to Grupo Landsteiner and the Creation of a Scalable Transcontinental Life Sciences Platform
Xlife Sciences AG announces strategic exit of 12 projects to Grupo Landsteiner, forming a transcontinental life sciences platform with a NASDAQ listing in 2026

Life Sciences Nasdaq Listing Xlife Sciences AG Strategic Exit Grupo Landsteiner
PRESS RELEASE

published on 12/08/2025 at 07:00, 2 months 12 days ago

Helvetia Baloise publishes Pro Forma Financial Information
Helvetia Baloise successfully completes merger with Baloise, forming Helvetia Baloise, Switzerland's largest insurer. Pro Forma Financial Information released showing accounting effects

Merger Intangible Assets Helvetia Baloise Pro Forma Financial Information IFRS Accounting Adjustments
PRESS RELEASE

published on 12/08/2025 at 07:00, 2 months 12 days ago

Sandoz completes strategic acquisition of Just-Evotec Biologics EU SAS, asserting biosimilars leadership
Sandoz completes strategic acquisition of Just-Evotec Biologics EU SAS, asserting biosimilars leadership. Expands capabilities for biosimilars with cutting-edge technology

Acquisition Biosimilars Sandoz Just-Evotec Biologics EU SAS Continuous-manufacturing Technology
PRESS RELEASE

published on 12/08/2025 at 07:00, 2 months 12 days ago

Evotec closes sale of Just – Evotec Biologics’ Toulouse site to Sandoz
Evotec closes sale of Just - Evotec Biologics' Toulouse site to Sandoz for over US$650m, including technology license fees. Sale improves revenue mix and profit margins

Technology Sale Evotec Sandoz Biologics
PRESS RELEASE

published on 12/08/2025 at 07:00, 2 months 12 days ago

Newron announces the US initiation of its ENIGMA-TRS 2 Phase III global clinical study with evenamide as an add-on therapy for patients with treatment-resistant schizophrenia (TRS)
Newron Pharmaceuticals initiates ENIGMA-TRS 2 Phase III global clinical study in US for treatment-resistant schizophrenia with evenamide as add-on therapy. Expecting results by Q4 2026

Newron Pharmaceuticals Evenamide Phase III Treatment-resistant Schizophrenia ENIGMA-TRS 2
PRESS RELEASE

published on 12/08/2025 at 04:30, 2 months 13 days ago

Family Support Now Make-or-Break for Overseas Postings, New Study Reveals
New research from AXA Global Healthcare reveals the importance of family support for international assignees, urging employers to adopt a more holistic approach. The 2025 World of Work Report emphasizes the impact on assignees' wellbeing and success criteria on global placements

Employee Wellbeing International Assignments AXA Global Healthcare Family Support Global Mobility

Accesswire

Published on 02/21/2026 at 00:45, 5 hours 5 minutes ago

Bocana Resources Corp. Extends Letter of Intent on Arizona Mining Claims for Additional Bulk Testing and Assay Review
Published on 02/21/2026 at 00:30, 5 hours 20 minutes ago

Redwood AI Corp. Announces Engagement for IR Services
Published on 02/20/2026 at 23:15, 6 hours 35 minutes ago

DigiPower X Announces Closing of Settlement
Published on 02/20/2026 at 23:00, 6 hours 50 minutes ago

Infinico Metals Corp. Announces Effective Date for 15-for-1 Common Share Consolidation
Published on 02/20/2026 at 22:17, 7 hours 33 minutes ago

Organto Foods Completes Warrant Exercise Incentive Program

View all ACCESSWIRE

EQS Group

Published on 02/20/2026 at 18:36, 11 hours 13 minutes ago

EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 18:31, 11 hours 18 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/20/2026 at 18:23, 11 hours 26 minutes ago

POS-Transaction in Own Shares
Published on 02/20/2026 at 18:00, 11 hours 50 minutes ago

Leclanché Secures Financing Arrangement in the amount of CHF 16.7 million to Support Near-Term Operations
Published on 02/20/2026 at 17:50, 12 hours ago

Modigliani Leads Templum’s Major International Auction

Les Echos

Published on 02/20/2026 at 19:29, 10 hours 20 minutes ago

SFPI GROUP: Liquidity agreement report S2 2025
Published on 02/20/2026 at 18:00, 11 hours 50 minutes ago

TERACT - Termination of liquidity agreement
Published on 02/20/2026 at 09:28, 20 hours 22 minutes ago

Statement about the number of shares composing the share capital and the number of voting rights as of January 31, 2026
Published on 02/20/2026 at 07:30, 22 hours 20 minutes ago

Announcement of share buyback in the context of a share purchase plan
Published on 02/20/2026 at 07:30, 22 hours 20 minutes ago

EURAZEO COMPLETES THE SALE OF EX NIHILO TO L CATTERTON

View all LES ECHOS COMFI WIRE